Clinical analysis of Moxifloxacin in treatment of acquired pneumonia
Abstract
Objective To investigate clinical effects of Moxifloxacin in treatment of acquired pneumonia.Methods From January 2010 to October 2011,66 patients with acquired pneumonia were randomly divided into observation group and control group,each group was 33 cases.Observation group were treated with moxifloxacin and control group with levofloxacin,10 days for a course.Results The total efficiency of 100.0% in the observation group and 81.9% in the control group.The total effective rate were significantly different(P0.05).Clearance rate of Klebsiella pneumoniae,Staphylococcus epidermidis,catarrhal bacteria,E.coli were 100%,there were no significant difference between two groups(P0.05),but clearance rate of Haemophilus influenzae,Pseudomonas aeruginosa,Staphylococcus aureus,pneumonia Streptococcus were significantly difference between two groups(P0.01).Conclusion Moxifloxacin have a good clinical efficacy and bacterial eradication rate in treatment of acquired pneumonia,it can be widely used.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.